Lean-seafood intake reduces cardiovascular lipid risk factors in healthy subjects: Results from a randomized controlled trial with a crossover design1,2

American Journal of Clinical Nutrition

Volumn 102, Issue 3, 2015, Pages 582-592

  Aadland, Eli Kristin ^a,c   Lavigne, Charles ^a   Graff, Ingvild Eide ^a   Eng, Øyvin ^d   Paquette, Martine ^e   Holthe, Asle ^c   Mellgren, Gunnar ^b,d   Jacques, Hélène ^e   Liaset, Bjørn ^a  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c BERGEN UNIVERSITY COLLEGE   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cardiovascular disease; Dietary protein; Lifestyle; Lipoproteins; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHYLOMICRON; DRINKING WATER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CARBOHYDRATE DIET; FAT INTAKE; MONOUNSATURATED FATTY ACID; PROTEIN INTAKE; UNSATURATED FATTY ACID;

ADULT; AMINO ACID COMPOSITION; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY COMPLIANCE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; LEAN SEAFOOD; LIPID COMPOSITION; MALE; MIDDLE AGED; NORMAL HUMAN; OUTCOME ASSESSMENT; PARTICLE SIZE; PHYSICAL ACTIVITY; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SEA FOOD; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL; ADMINISTRATION AND DOSAGE; BLOOD; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASES; DIET; DIET RESTRICTION; FAT INTAKE; POSTPRANDIAL STATE; RISK FACTOR;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHYLOMICRONS; CROSS-OVER STUDIES; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; ENERGY INTAKE; FASTING; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; RISK FACTORS; SEAFOOD; TRIGLYCERIDES;

EID: 84941615261     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.112086     Document Type: Article

References (50)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:e28-292.
2. Akesson A, Larsson SC, Discacciati A, Wolk A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study. J Am Coll Cardiol 2014;64:1299-306.
3. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 2006;114:160-7.
4. Eguchi E, Iso H, Tanabe N, Wada Y, Yatsuya H, Kikuchi S, Inaba Y, Tamakoshi A. Healthy lifestyle behaviours and cardiovascular mortality among Japanese men and women: the Japan collaborative cohort study. Eur Heart J 2012;33:467-77.
5. Odegaard AO, Koh WP, Gross MD, Yuan JM, Pereira MA. Combined lifestyle factors and cardiovascular disease mortality in Chinese men and women: the Singapore Chinese health study. Circulation 2011;124: 2847-54.
6. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.
7. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation 2010; 121:586-613.
8. Mozaffarian D. Achieving cardiovascular health: a bleak outlook or tremendous potential? J Am Coll Cardiol 2011;57:1697-9.
9. de Lorgeril M, Renaud S, Salen P, Monjaud I, Mamelle N, Martin JL, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acidrich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
10. de Lorgeril M, Salen P, Martin J-L, Mamelle N, Monjaud I, Touboul P, Delaye J. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol 1996;28:1103-8.
11. de Lorgeril M, Salen P, Martin J-L, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.
12. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-90.
13. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004; 109:2705-11.
14. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287:1815-21.
15. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: new insights. Circulation 2011;123:2870-91.
16. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010;122:876-83.
17. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011;58:2047-67.
18. Kromhout D, Bosschieter EB. Coulander CdL. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
19. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, Sweetnam PM, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-61.
20. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.Lancet 1999;354:447-55
21. Moore CS, Bryant SP, Mishra GD, Krebs JD, Browning LM, Miller GJ, Jebb SA. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women. Nutrition 2006;22:1012-24.
22. Oh PC, Koh KK, Sakuma I, Lim S, Lee Y, Lee S, Lee K, Han SH, Shin EK. Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia. Int J Cardiol 2014;176:696-702.
23. Gascon A, Jacques H, Moorjani S, Deshaies Y, Brun LD, Julien P. Plasma lipoprotein profile and lipolytic activities in response to the substitution of lean white fish for other animal protein sources in premenopausal women. Am J Clin Nutr 1996;63:315-21.
24. Jacques H, Noreau L, Moorjani S. Effects on plasma lipoproteins and endogenous sex hormones of substituting lean white fish for other animal-protein sources in diets of postmenopausal women. Am J Clin Nutr 1992;55:896-901.
25. Lacaille B, Julien P, Deshaies Y, Lavigne C, Brun LD, Jacques H. Responses of plasma lipoproteins and sex hormones to the consumption of lean fish incorporated in a prudent-type diet in normolipidemic men. J Am Coll Nutr 2000;19:745-53.
26. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-85.
27. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker P. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16.
28. Nordestgaard BG, Benn M, Schnohr P, Tybjærg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308.
29. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet 2014;384:626-35.
30. Andersen LF, Tomten H, Haggarty P, Lovo A, Hustvedt BE. Validation of energy intake estimated from a food frequency questionnaire: a doubly labelled water study. Eur J Clin Nutr 2003;57:279-84.
31. The Norwegian Directorate of Health. Dietary advice for the promotion of public health and the prevention of chronic diesases. Oslo (Norway): Directorate of Health, 2011. p. 356 (in Norwegian).
32. The Nordic Council of Ministers. Nordic nutrition recommendations: integrating nutrition and physical activity. 4th ed. Copenhagen (Denmark): The Nordic Council of Ministers, 2004.
33. Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci USA 1918;4:370-3.
34. Wellek S, Blettner M. Establishing equivalence or non-inferiority in clinical trials. Dtsch Arztebl Int 2012;109:674-9.
35. Hills M, Armitage P. The two-period crossover clinical-trial. Br J Clin Pharmacol 1979;8:7-20.
36. Lajous M, Willett WC, Robins J, Young JG, Rimm E, Mozaffarian D, Hernán MA. Changes in fish consumption in midlife and the risk of coronary heart disease in men and women. Am J Epidemiol 2013; 178:382-91.
37. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G,Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V. Triglycerides and the risk of coronary heart disease-10 158 incident cases among 262 525 participants in 29 Western prospective studies. Circulation 2007;115:450-8.
38. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KR, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000.
39. Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010;375:1634-9.
40. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011;123:2292-333.
41. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39.
42. Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet 2014; 384:618-25.
43. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009;119:931-9.
44. McQueen MJ, Hawken S,Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-33.
45. Tremblay AJ, Sniderman AD, Gagné C, Bergeron J, Couture P. Differential impact of plasma triglycerides on HDL-cholesterol and HDLapo A-1 in a large cohort. Clin Biochem 2007;40:25-9.
46. Rashid S, Watanabe T, Sakaue T, Lewis GF. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem 2003;36:421-9.
47. Adiels M, Olofsson SO, Taskinen MR, Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28: 1225-36.
48. Adiels M,Westerbacka J, Soro-Paavonen A, Hakkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Jarvinen H, Taskinen MR, et al. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007;50:2356-65.
49. Ouellet V, Marois J, Weisnagel SJ, Jacques H. Dietary cod protein improves insulin sensitivity in insulin-resistant men and women. Diabetes Care 2007;30:2816-21.
50. Erkkilä AT, Schwab US, Lehto S, de Mello VD, Kangas AJ, Soininen P, Ala-Korpela M, Uusitupa MIJ. Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: a controlled trial. J Clin Lipidol 2014;8:126-33.